Metformin:A promising clinical therapeutical approach for BPH treatment via inhibiting dysregulated steroid hormones-induced prostatic epithelial cells proliferation
10.1016/j.jpha.2023.08.012
- Author:
Tingting YANG
1
;
Jiayu YUAN
;
Yuting PENG
;
Jiale PANG
;
Zhen QIU
;
Shangxiu CHEN
;
Yuhan HUANG
;
Zhenzhou JIANG
;
Yilin FAN
;
Junjie LIU
;
Tao WANG
;
Xueyan ZHOU
;
Sitong QIAN
;
Jinfang SONG
;
Yi XU
;
Qian LU
;
Xiaoxing YIN
Author Information
1. Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy,Xuzhou Medical University,Xuzhou,Jiangsu,221004,China
- Keywords:
Metformin;
Benign prostatic hyperplasia;
Sex steroid hormones homeostasis;
Proliferation;
DHT;
YAP1-TEAD4 heterodimer
- From:
Journal of Pharmaceutical Analysis
2024;14(1):52-68
- CountryChina
- Language:Chinese
-
Abstract:
The occurrence of benign prostate hyperplasia(BPH)was related to disrupted sex steroid hormones,and metformin(Met)had a clinical response to sex steroid hormone-related gynaecological disease.How-ever,whether Met exerts an antiproliferative effect on BPH via sex steroid hormones remains unclear.Here,our clinical study showed that along with prostatic epithelial cell(PEC)proliferation,sex steroid hormones were dysregulated in the serum and prostate of BPH patients.As the major contributor to dysregulated sex steroid hormones,elevated dihydrotestosterone(DHT)had a significant positive rela-tionship with the clinical characteristics of BPH patients.Activation of adenosine 5'-monophosphate(AMP)-activated protein kinase(AMPK)by Met restored dysregulated sex steroid hormone homeostasis and exerted antiproliferative effects against DHT-induced proliferation by inhibiting the formation of androgen receptor(AR)-mediated Yes-associated protein(YAP1)-TEA domain transcription factor(TEAD4)heterodimers.Met's anti-proliferative effects were blocked by AMPK inhibitor or YAP1 over-expression in DHT-cultured BPH-1 cells.Our findings indicated that Met would be a promising clinical therapeutic approach for BPH by inhibiting dysregulated steroid hormone-induced PEC proliferation.
